About lotus leaf

Lotus leaf is a flowering aquatic perennial that grows widely throughout tropical regions of Asia and the Middle East. The pale green leaves are flat and broad, reaching up to 18 inches in diameter. The leaves are usually collected in the summer and autumn and dried before being cut into small pieces, powdered or processed into pills. Lotus leaves are touted to be useful in treating a variety of conditions, including heavy bleeding, diarrhea and muscle spasms.   

lotus leaf extract Nuciferine
Product Name:Lotus Leaf Extract    
Latin Name:Folium Nelumbinis
Active Ingredient:Nuciferine 1% 2% 5% 10% 50%,98%
Test Method:HPLC
Extraction Solvent:Ethanol/ Water
CAS NO:475-83-2
Molecular Formula:C19H21NO2
Molecular Weight:313.39082

Lotus leaf extract Application:

1.Applied in food field, lotus leaf become a delicious and healthy green food;

2.Applied in health product field, lotus leaf slimming tea by the majority of ladys love;

3.Applied in pharmaceutical field, it can promote the growth of bone.

4.Applied in Dietary Supplement, it is greatest fat burner, reduce fat, depress blood pressure.

Staherb natural ingredients-----professional manufacturer of magnolia bark extract,vine tea extract,myricetin,honeysuckle flower extract,eucommia leaf extract,rosemary extract,macleaya cordata extract,banaba leaf extract.

Remarks:

The above information about lotus leaf extract is from the Internet and literature for reference only.

Changsha staherb natrual ingredients co.,ltd is a professional standardized plant extract production enterprise,the products are only for enterprise customers.

References:

1.Zhang X, Xu R, Zhang C, Xu Y, Han M, Huang B, et al. Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination. J Exp Clin Cancer Res. 2017;36(1):118.

2.Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Dowell JM, Reardon DA, Quinn JA, et al. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res. 2007;13(4):1253–9.

3.Kim BM, Hong Y, Lee S, Liu P, Lim JH, Lee YH, et al. Therapeutic implications for overcoming radiation resistance in cancer therapy. Int J Mol Sci. 2015;16(11):26880–913.

4.Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128–34. 

5.Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21–45.

6.Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017 Oct;14(10):611–29.

7.Phillips S, Kuperwasser C. SLUG: critical regulator of epithelial cell identity in breast development and cancer. Cell Adhes Migr. 2014;8(6):578–87.

8.Voutsadakis IA. Epithelial-mesenchymal transition (EMT) and regulation of EMT factors by steroid nuclear receptors in breast cancer: a review and in silico investigation. J Clin Med. 2016;5(1):E11.

9.Alves CC, Carneiro F, Hoefler H, Becker KF. Role of the epithelial-mesenchymal trasition regulator Slug in primary human cancers. Front Biosci (Landmark Ed). 2009;14:3035–50.

10.Wegner M. From head to toes: the multiple facets of sox proteins. Nucleic Acids Res. 1999;27(6):1409–20.

11.Mansouri S, Nejad R, Karabork M, Ekinci C, Solaroglu I, Aldape KD, et al. Sox2: regulation of expression and contribution to brain tumors. CNS Oncol. 2016;5(3):159–73.

12.Song WS, Yang YP, Huang CS, Lu KH, Liu WH, Wu WW, et al. Sox2, stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc. 2016;79(10):538–45.

13.Garros-Regulez L, Garcia I, Carrasco-Garcia E, Lantero A, Aldaz P, Moreno-Cugnon L, et al. Targeting SOX2 as a therapeutic strategy in glioblastoma. Front Oncol. 2016;6:222.

14.Chin YW, Yoon KD, Kim J. Cytotoxic anticancer candidates from terrestrial plants. Anti Cancer Agents Med Chem. 2009;9(8):913–42.

15.Mangal M, Sagar P, Singh H, Raghava GP, Agarwal SM. NPACT: naturally occurring plant-based anti-cancer compound-activity-target database. Nucleic Acids Res. 2013;41:D1124–9.

16.Nguyen KH, Ta TN, Pham TH, Nguyen QT, Pham HD, Mishra S, et al. Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide. J Ethnopharmacol. 2012;142(2):488–95. 

Changsha Staherb Natural Ingredients Co., Ltd., 
---a good supplier of professional herb extracts
If you wanna know more about us, please feel free to contact me at:
Whatsapp: +86 13548561509
Email: staherb18@staherb.cn   info@staherb.cn   staherb09@staherb.cn   sales05@staherb.cn
Web：www.staherb.cn    www.natural-ingredient.net/
or you can send me online message if it's convenient for you.
We look forward to cooperating with you!